Cited by 61Sleep and related disordersSleep and Wakefulness ResearchSleep and Work-Related Fatigue

HYPNOTIC EFFICACY OF TEMAZEPAM: A LONG‐TERM SLEEP LABORATORY EVALUATION

Open access
MITLER, M.M., CARSKADON, MARY A., PHILLIPS, R.L, STERLING, W.R., ZARCONE, V.P., SPIEGEL, R., GUILLEMINAULT, C., DEMENT, W.C.·1979·British Journal of Clinical Pharmacology

Abstract

Temazepam was evaluated in a strictly defined insomniac patient population under sleep laboratory conditions. Two protocols were used: a short‐term (26‐night) and a long‐term (54‐night) protocol evaluated the efficacy of the drug administered at night at 15 mg (short‐term study) and 30 mg (long‐term study), respectively. Temazepam seemed to be both safe and effective at doses of 15 and 30 mg with up to 5 weeks of ingestion. Suppression of slow wave sleep was observed at the high dose, but no suppression of REM sleep, found in studies with other benzodiazepines, was noted. No evidence was found for development of tolerance or rebound effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.1979.tb00459.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rebound insomnia upon abrupt cessation of benzodiazepines after short-term use was confirmed by other studies.

    “This was confirmed by other studies [53-59].”

    From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [57]

    The Discussion (page not specified in our copy) says the study found no evidence of rebound insomnia after abrupt withdrawal of temazepam. Although this paper evaluated a short-term protocol, it does not confirm the attributed finding; it reports the opposite for the benzodiazepine it studied. (LLM, conf=0.91)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [8]8. RECHTSCHAFFEN, A. & KALES, A. (ed.) (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Public Health Service Publication No. 204. Washington, DC: US Government Printing Office.

Cited by

Sorted by citations

Authors
MITLER, M. M., CARSKADON, M. A., PHILLIPS, R. L., STERLING, W. R., ZARCONE, V. P., SPIEGEL, R., GUILLEMINAULT, C., & DEMENT, W. C.
Affiliations
  • State University of New York (US)
  • Stanford Medicine (US)
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1979-04
Volume
8
Issue
Supplement s1
Pages
63S-68S
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1966581042
Cited by
60
References
9
Citations by year
2020: 1 · 2012: 1
FWCI
6.09
Type
journal article
Language
en
Open access
Locations
  • British Journal of Clinical Pharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
temazepam, hypnotic efficacy, insomnia, long-term drug use, REM sleep, benzodiazepines, drug tolerance, rebound effect, sleep laboratory
MeSH terms
Adult, Clinical Trials as Topic, Drug Tolerance, Electroencephalography, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Sleep, REM, Temazepam, Time Factors, Anti-Anxiety Agents, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review